SARS-CoV-2感染患者院外心脏骤停的结局:系统评价与荟萃分析
该系统评价与荟萃分析检索至2021年4月5日,纳入10项比较SARS-CoV-2感染与否的院外心脏骤停研究。感染患者占18%(1341/7545),出院或30天生存率1.9% vs 6.5%(OR=0.33),自主循环恢复率22% vs 27%(OR=0.75),救护车到达更晚(15±10 vs 13±7.5 min),不可电击心律更多(93% vs 82%,OR=2.79),家中发生心脏骤停更常见(94% vs 89%,OR=1.86),但目击率和旁观者CPR率相似。
要点
- SARS-CoV-2感染患者院外心脏骤停后生存率仅1.9%,显著低于未感染者的6.5%(OR=0.33,95%CI 0.17-0.65)。
- 感染患者自主循环恢复率22% vs 27%(OR=0.75,95%CI 0.65-0.86),不可电击心律占93% vs 82%(OR=2.79)。
- 感染患者救护车到达时间更长(15±10 vs 13±7.5 min,均差1.64 min),家中发生心脏骤停比例更高(94% vs 89%)。
- 目击率(55% vs 56%)和旁观者启动CPR率(53% vs 51%)在感染与非感染患者间无显著差异。
- 约18%的院外心脏骤停患者存在SARS-CoV-2感染,提示疫情期间院外心脏骤停患者中感染比例较高。
适用人群与场景
- 纳入比较院外心脏骤停患者中疑似或确诊SARS-CoV-2感染与未感染者的研究,场景为院外心脏骤停。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 系统评价与荟萃分析,纳入10项研究,共7545例院外心脏骤停患者,其中1341例(18%)感染SARS-CoV-2。
- 主要终点出院或30天生存率:感染组1.9%(16/856) vs 未感染组6.5%(153/2344),OR=0.33(95%CI 0.17-0.65,P=0.001,I2=28%)。
- 自主循环恢复率:感染组22%(188/861) vs 未感染组27%(640/2403),OR=0.75(95%CI 0.65-0.86,P<0.001,I2=0%)。
- 不可电击心律:感染组93%(744/803) vs 未感染组82%(1828/2217),OR=2.79(95%CI 2.08-3.73,P<0.001,I2=0%)。
- 救护车到达时间:感染组15±10 min vs 未感染组13±7.5 min,均差1.64 min(95%CI 0.41-2.88,P=0.009,I2=61%)。
- 家中发生心脏骤停:感染组94%(1186/1263) vs 未感染组89%(3598/4055),OR=1.86(95%CI 1.45-2.40,P<0.001,I2=0%)。
- 目击率:感染组55%(486/890) vs 未感染组56%(1385/2475),OR=0.97(95%CI 0.82-1.14,P=0.63,I2=0%);旁观者启动CPR率:感染组53%(439/828) vs 未感染组51%(1164/2304),OR=0.95(95%CI 0.73-1.24,P=0.70,I2=53%)。
证据类型、等级与局限
- 系统评价与荟萃分析,检索PubMed和EMBASE至2021年4月5日,纳入10项比较SARS-CoV-2感染与否的院外心脏骤停研究;原文未给出证据等级或推荐强度;局限性包括观察性研究设计、各研究间救护车到达时间异质性较高(I2=61%)。
对床旁实践的改变
- 对院外心脏骤停患者应考虑到SARS-CoV-2感染可能(约占18%),并注意感染患者自主循环恢复率和生存率更低、不可电击心律更常见。
- 感染患者救护车到达时间更长且更常在家中发生心脏骤停,提示疫情期间院前急救系统需关注响应延迟和家庭场景的复苏挑战。
- 目击率和旁观者CPR率在感染与非感染患者间相似,不支持因感染状态而减少旁观者CPR的推测。
指南或共识出处
- PROSPERO注册号CRD42021243540;原文未提及具体指南或共识名称。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: Out-of-hospital cardiac arrests increased during the COVID-19 pandemic and a direct mechanism of cardiac arrest in infected patients was hypothesized. Therefore, we conducted a systematic review and meta-analysis to assess outcomes of SARS-CoV-2 patients with out-of-hospital cardiac arrest.
METHODS: PubMed and EMBASE were searched up to April 05, 2021. We included studies comparing out-of-hospital cardiac arrests patients with suspected or confirmed SARS-CoV-2 infection versus noninfected patients. The primary outcome was survival at hospital discharge or at 30 days. Secondary outcomes included return of spontaneous circulation, cardiac arrest witnessed and occurring at home, bystander-initiated cardiopulmonary resuscitation, proportion of nonshockable rhythm and resuscitation attempted, and ambulance arrival time.
RESULTS: In the ten included studies, 18% (1341/7545) of out-of-hospital cardiac arrests occurred in patients with SARS-CoV-2 infection. Patients with out-of-hospital cardiac arrest and SARS-CoV-2 infection had reduced rates of survival (16/856 [1.9%] vs. 153/2344 [6.5%]; odds ratio (OR) = 0.33; 95% confidence interval (CI), 0.17-0.65; P = 0.001; I2 = 28%) and return of spontaneous circulation (188/861 [22%] vs. 640/2403 [27%]; OR = 0.75; 95% CI, 0.65-0.86; P < 0.001; I2 = 0%) when compared to noninfected patients. Ambulance arrived later (15 ± 10 vs. 13 ± 7.5 min; mean difference = 1.64; 95% CI, 0.41-2.88; P = 0.009; I2 = 61%) and nonshockable rhythms (744/803 [93%] vs. 1828/2217 [82%]; OR = 2.79; 95% CI, 2.08-3.73; P < 0.001; I2 = 0%) occurred more frequently. SARS-CoV-2 positive patients suffered a cardiac arrest at home more frequently (1186/1263 [94%] vs. 3598/4055 [89%]; OR = 1.86; 95% CI, 1.45-2.40; P<0.001; I2 = 0%) but witnessed rate (486/890 [55%] vs. 1385/2475 [56%]; OR = 0.97; 95% CI, 0.82-1.14; P = 0.63; I2 = 0%) and bystander-initiated cardiopulmonary resuscitation rate (439/828 [53%] vs. 1164/2304 [51%]; OR = 0.95; 95% CI, 0.73-1.24; P = 0.70; I2 = 53%) were similar.
CONCLUSIONS: One-fifth of out-of-hospital cardiac arrest patients had SARS-CoV-2 infection. These patients had low rates of return of spontaneous circulation and survival and were characterized by higher nonshockable rhythms but similar bystander-initiated cardiopulmonary resuscitation rate.
REVIEW REGISTRATION: PROSPERO - CRD42021243540.
参考来源
- Scquizzato T, Landoni G, Scandroglio AM, et al. Outcomes of out-of-hospital cardiac arrest in patients with SARS-CoV-2 infection: a systematic review and meta-analysis. Eur J Emerg Med. 2021. PMID: 34690258. doi:10.1097/MEJ.0000000000000878
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。